Advantages and Versatility of Fluorescence-Based Methodology to Characterize the Functionality of LDLR and Class Mutation Assignment

Goldstein JL HH, Brown MS (2001) Familial hypercholesterolemia; C.R. Scriver ALB, W.S. Sly and D. Valle, Editors, editor. New York McGraw-Hill.

RM Ned, 2011, Cascade Screening for Familial Hypercholesterolemia (FH), PLoS Curr, 3, RRN1238

E Usifo, 2012, Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment, Ann Hum Genet, 76, 387, 10.1111/j.1469-1809.2012.00724.x

HH Hobbs, 1988, Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions, J Clin Invest, 81, 909, 10.1172/JCI113402

JL Goldstein, 1985, Receptor-mediated endocytosis: concepts emerging from the LDL receptor system, Annu Rev Cell Biol, 1, 1, 10.1146/annurev.cb.01.110185.000245

HH Hobbs, 1992, Molecular genetics of the LDL receptor gene in familial hypercholesterolemia, Hum Mutat, 1, 445, 10.1002/humu.1380010602

CG Davis, 1986, The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors, Cell, 45, 15, 10.1016/0092-8674(86)90533-7

MA Lehrman, 1985, Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain, Cell, 41, 735, 10.1016/S0092-8674(85)80054-4

N Beglova, 2004, Cooperation between fixed and low pH-inducible interfaces controls lipoprotein release by the LDL receptor, Mol Cell, 16, 281, 10.1016/j.molcel.2004.09.038

SE Leigh, 2008, Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database, Ann Hum Genet, 72, 485, 10.1111/j.1469-1809.2008.00436.x

S Silva, 2012, In vitro functional characterization of missense mutations in the LDLR gene, Atherosclerosis, 225, 128, 10.1016/j.atherosclerosis.2012.08.017

BL Knight, 1982, Changes in the metabolism of modified and unmodified low-density lipoproteins during the maturation of cultured blood monocyte-macrophages from normal and homozygous familial hypercholesterolaemic subjects, Eur J Biochem, 125, 407, 10.1111/j.1432-1033.1982.tb06698.x

TP Leren, 1997, Molecular genetics of familial hypercholesterolaemia in Norway, J Intern Med, 241, 185, 10.1046/j.1365-2796.1997.78119000.x

T Ranheim, 2006, Model system for phenotypic characterization of sequence variations in the LDL receptor gene, Clin Chem, 52, 1469, 10.1373/clinchem.2006.068627

M Romano, 2011, An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations, J Lipid Res, 52, 2095, 10.1194/jlr.D017772

XM Sun, 1997, Comparison of the genetic defect with LDL-receptor activity in cultured cells from patients with a clinical diagnosis of heterozygous familial hypercholesterolemia. The Familial Hypercholesterolaemia Regression Study Group, Arterioscler Thromb Vasc Biol, 17, 3092, 10.1161/01.ATV.17.11.3092

H Tada, 2009, A novel method for determining functional LDL receptor activity in familial hypercholesterolemia: application of the CD3/CD28 assay in lymphocytes, Clin Chim Acta, 400, 42, 10.1016/j.cca.2008.10.010

JT den Dunnen, 2000, Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion, Hum Mutat, 15, 7, 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N

PE Taschner, 2011, Describing structural changes by extending HGVS sequence variation nomenclature, Hum Mutat, 32, 507, 10.1002/humu.21427

IA Adzhubei, 2010, A method and server for predicting damaging missense mutations, Nat Methods, 7, 248, 10.1038/nmeth0410-248

PC Ng, 2003, SIFT: Predicting amino acid changes that affect protein function, Nucleic Acids Res, 31, 3812, 10.1093/nar/gkg509

A Gonzalez-Perez, 2011, Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel, Am J Hum Genet, 88, 440, 10.1016/j.ajhg.2011.03.004

JM Schwarz, 2010, MutationTaster evaluates disease-causing potential of sequence alterations, Nat Methods, 7, 575, 10.1038/nmeth0810-575

R Grantham, 1974, Amino acid difference formula to help explain protein evolution, Science, 185, 862, 10.1126/science.185.4154.862

KS Pollard, 2010, Detection of nonneutral substitution rates on mammalian phylogenies, Genome Res, 20, 110, 10.1101/gr.097857.109

JL Goldstein, 1974, Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia, J Biol Chem, 249, 5153, 10.1016/S0021-9258(19)42341-7

AK Soutar, 1989, Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors, Proc Natl Acad Sci U S A, 86, 4166, 10.1073/pnas.86.11.4166

R Dardik, 2000, Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation, Thromb Haemost, 83, 338, 10.1055/s-0037-1613809

J Hed, 1987, The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation, J Immunol Methods, 101, 119, 10.1016/0022-1759(87)90224-9

A Etxebarria, 2012, Functional characterization of splicing and ligand-binding domain variants in the LDL receptor, Hum Mutat, 33, 232, 10.1002/humu.21630

H Jeon, 2001, Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair, Nat Struct Biol, 8, 499, 10.1038/88556

Minino AM, Xu J, Kochanek KD, Tejada-Vera B (2009) Death in the United States, 2007. NCHS Data Brief: 1–8.

A Terzic, 2011, Chronic diseases: the emerging pandemic, Clin Transl Sci, 4, 225, 10.1111/j.1752-8062.2011.00295.x

SA Waldman, 2011, Cardiovascular health: the global challenge, Clin Pharmacol Ther, 90, 483, 10.1038/clpt.2011.213

AC Alves, 2010, Molecular diagnosis of familial hypercholesterolemia: an important tool for cardiovascular risk stratification, Rev Port Cardiol, 29, 907

A Haase, 2012, Identification of people with heterozygous familial hypercholesterolemia, Curr Opin Lipidol, 23, 282, 10.1097/MOL.0b013e3283556c33

BG Nordestgaard, 2013, Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society, Eur Heart J, 34, 3478, 10.1093/eurheartj/eht273

P Brice, 2013, Familial hypercholesterolaemia: a pressing issue for European health care, Atherosclerosis, 231, 223, 10.1016/j.atherosclerosis.2013.09.019

MS Brown, 1975, Regulation of the activity of the low density lipoprotein receptor in human fibroblasts, Cell, 6, 307, 10.1016/0092-8674(75)90182-8